Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
62
INFU Quote, Financials, Valuation and Earnings
Last price:
$8.38
Seasonality move
:
2.4%
Day range:
$7.83 - $8.45
52-week range:
$5.74 - $10.89
Dividend yield:
0%
P/E ratio:
131.26x
P/S ratio:
1.35x
P/B ratio:
3.18x
Volume:
127.7K
Avg. volume:
87.9K
1-year change:
-21.38%
Market cap:
$176.7M
Revenue:
$125.8M
EPS (TTM):
$0.06
Analysts' Opinion
-
Consensus RatingInfuSystems Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, InfuSystems Holdings has an estimated upside of 69.98% from its current price of $8.31.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $8.31.
Fair Value
-
According to the consensus of 0 analysts, InfuSystems Holdings has 69.98% upside to fair value with a price target of -- per share.
INFU vs. S&P 500
-
Over the past 5 trading days, InfuSystems Holdings has underperformed the S&P 500 by -4.84% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
InfuSystems Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
InfuSystems Holdings has grown year-over-year revenues for 13 quarters straight. In the most recent quarter InfuSystems Holdings reported revenues of $35.3M.
Earnings Growth
-
InfuSystems Holdings has grown year-over-year earnings for 2 quarters straight. In the most recent quarter InfuSystems Holdings reported earnings per share of $0.08.
Enterprise value:
204.3M
EV / Invested capital:
2.45x
Price / LTM sales:
1.35x
EV / EBIT:
37.55x
EV / Revenue:
1.54x
PEG ratio (5yr expected):
2.25x
EV / Free cash flow:
82.91x
Price / Operating cash flow:
72.79x
Enterprise value / EBITDA:
11.57x
Gross Profit (TTM):
$68.9M
Return On Assets:
1.42%
Net Income Margin (TTM):
1.12%
Return On Equity:
2.8%
Return On Invested Capital:
1.77%
Operating Margin:
9.24%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $107.6M | $122.8M | $132.8M | $31.9M | $35.3M | |
| Gross Profit | $60.1M | $60.5M | $68.9M | $15.6M | $19M | |
| Operating Income | $2.2M | $3.9M | $5.5M | $1.7M | $3.3M | |
| EBITDA | $16M | $16.2M | $17.7M | $4.8M | $6.4M | |
| Diluted EPS | $0.01 | $0.04 | $0.06 | $0.03 | $0.08 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $21.4M | $21.9M | $23.6M | $29.7M | $33.6M | |
| Total Assets | $80.3M | $94.8M | $99M | $102.1M | $105.3M | |
| Current Liabilities | $19.7M | $14.5M | $12.7M | $14.3M | $16.9M | |
| Total Liabilities | $50.9M | $48.3M | $51.2M | $50.6M | $49.8M | |
| Total Equity | $29.4M | $46.5M | $47.8M | $51.5M | $55.5M | |
| Total Debt | $34.8M | $30.9M | $34.5M | $32.7M | $28M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $16.7M | $11.1M | $17.2M | $4.3M | $9.8M | |
| Cash From Investing | -$14.1M | -$8.7M | -$11M | -$300K | -$2.9M | |
| Cash From Financing | -$2.4M | -$2.6M | -$6M | -$3.9M | -$6.8M | |
| Free Cash Flow | -$765K | -$2M | $2.5M | $2.6M | $6.4M | |
INFU
Sector
Market Cap
$176.7M
$44.6M
Price % of 52-Week High
76.31%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
2.28%
-0.68%
1-Year Price Total Return
-21.38%
-29.09%
Beta (5-Year)
1.528
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$8.69
200-day SMA
Buy
Level
$7.35
Bollinger Bands (100)
Buy
Level
6.05 - 8.37
Chaikin Money Flow
Sell
Level
-2.9M
20-day SMA
Sell
Level
$8.89
Relative Strength Index (RSI14)
Sell
Level
45.67
ADX Line
Sell
Level
12.68
Williams %R
Neutral
Level
-65
50-day SMA
Buy
Level
$8.01
MACD (12, 26)
Buy
Level
0.07
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
156.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.376)
Buy
CA Score
(Annual)
Level (0.1835)
Buy
Beneish M-Score
(Annual)
Level (-2.7135)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (0.3309)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.
Stock Forecast FAQ
In the current month, INFU has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The INFU average analyst price target in the past 3 months is --.
-
Where Will InfuSystems Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that InfuSystems Holdings share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About InfuSystems Holdings?
Analysts are divided on their view about InfuSystems Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that InfuSystems Holdings is a Sell and believe this share price will drop from its current level to --.
-
What Is InfuSystems Holdings's Price Target?
The price target for InfuSystems Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is INFU A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for InfuSystems Holdings is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of INFU?
You can purchase shares of InfuSystems Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase InfuSystems Holdings shares.
-
What Is The InfuSystems Holdings Share Price Today?
InfuSystems Holdings was last trading at $8.38 per share. This represents the most recent stock quote for InfuSystems Holdings. Yesterday, InfuSystems Holdings closed at $8.31 per share.
-
How To Buy InfuSystems Holdings Stock Online?
In order to purchase InfuSystems Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
